Bruker insider plans sale of 2,000 shares

Bruker Corporation insider Mark R. Munch has filed a Rule 144 notice to sell 2,000 shares of the company’s common stock.

Rhea-AI Filing Summary

Bruker Corporation insider Mark R. Munch has filed a Rule 144 notice to sell 2,000 shares of the company’s common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 01/15/2026 and an aggregate market value of $98,400. The securities were acquired on 01/15/2026 by exercising stock options granted by the issuer and were paid for in cash.

Over the prior three months, the same seller reported additional open-market sales of Bruker common stock. On 01/12/2026, 7,000 shares were sold for gross proceeds of $385,000, and on 01/05/2026, 33,843 shares were sold for gross proceeds of $1,680,704. The notice includes a representation that the seller does not know any material adverse, non-public information about Bruker’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction does Bruker (BRKR) report in this Form 144?

The notice shows Mark R. Munch intends to sell 2,000 shares of Bruker common stock, acquired by stock option exercise and to be sold under Rule 144.

How and when were the 2,000 Bruker (BRKR) shares acquired?

The 2,000 common shares were acquired on 01/15/2026 through a stock option exercise from the issuer, with the exercise price paid in cash on the same date.

What are the planned sale terms for the new Bruker (BRKR) shares?

The Form 144 states the 2,000 common shares, with an aggregate market value of $98,400, are expected to be sold on or about 01/15/2026 on NASDAQ through Morgan Stanley Smith Barney LLC.

What Bruker (BRKR) shares has the insider sold in the last 3 months?

The filing lists two recent sales by Mark R. Munch: 7,000 shares on 01/12/2026 for $385,000 and 33,843 shares on 01/05/2026 for $1,680,704 in gross proceeds.

How many Bruker (BRKR) shares are outstanding in this Form 144?

The notice reports 151,941,144 Bruker common shares outstanding, which is provided as context for the 2,000-share planned sale.

What representation does the Bruker (BRKR) insider make in this notice?

By signing the notice, the seller represents that they do not know any material adverse information about Bruker’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/15/2026 - 04:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001544635
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bruker Corporation
SEC File Number	001-42828
Address of Issuer	40 Manning Road Billerica, MASSACHUSETTS 01821
Phone	978-663-3660
Name of Person for Whose Account the Securities are To Be Sold	MARK R MUNCH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2000	98400.00	151941144	01/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2026	Stock Option Exercise	ISSUER			2000	01/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARK R MUNCH 40 Manning Road Billerica, MA 01821	Common	01/12/2026	7000	385000.00
MARK R MUNCH 40 Manning Road Billerica, MA 01821	Common	01/05/2026	33843	1680704.00

144: Remarks and Signature

Remarks
Date of Notice	01/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark Munch
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)